26 May 2013
Keywords: Teva, Procter & Gamble, OTC medicines, Joint venture, Consumer health care
Article | 25 March 2011
US consumer products conglomerate Procter & Gamble (NYSE: PG) and Israel-based Teva Pharmaceutical Industries (Nasdaq: TEVA) have signed an agreement ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.